Provided by Tiger Fintech (Singapore) Pte. Ltd.

PDL BioPharma

2.47
0.0000
Volume:- -
Turnover:- -
Market Cap:281.54M
PE:-1.87
High:2.47
Open:2.47
Low:2.47
Close:2.47
Loading ...
May 04, 2020

Major Issues Report

Current report, item 5.02
Apr 29, 2020

[Rev.]Annual Report

[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2020

Major Issues Report

Current report, items 2.02, 7.01, and 9.01
Mar 10, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 09, 2020

Major Issues Report

Current report, items 5.02 and 9.01
Feb 28, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Feb 28, 2020

Major Issues Report

Current report, items 1.01, 5.02, and 9.01
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 05, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 15, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Jan 09, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Dec 23, 2019

Major Issues Report

Current report, item 5.02
Dec 19, 2019

Major Issues Report

Current report, items 5.02 and 9.01
Dec 16, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Dec 13, 2019

Major Issues Report

Current report, items 3.02, 7.01, and 9.01
Dec 09, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Nov 19, 2019

Major Issues Report

Current report, item 5.02